E.W. Muller

Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial

Annemieke Cats, Edwin P. M. Jansen, Nicole C.T. van Grieken et al. · The Lancet Oncology · 2018 · 562 citations

Surgical Oncology, Chemotherapy Versus Chemoradiotherapy, Gastrointestinal Oncology +8

Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial

A.J. Breugom, W. van Gijn, E.W. Muller et al. · Annals of Oncology · 2014 · 383 citations · Full text

Rectal Cancer Patients, Surgical Oncology, Radiation Therapy +10

Lethal outcome of a patient with a complete dihydropyrimidine dehydrogenase (DPD) deficiency after administration of 5-fluorouracil: frequency of the common IVS14+1G>A mutation causing DPD deficiency.

André B. P. Kuilenburg, E.W. Muller, Janet Haasjes et al. · PubMed · 2001 · 255 citations

Dpd Gene, Genetic Disorder, Genetics +13

Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial

Vivianne C. G. Tjan‐Heijnen, Irene E.G. van Hellemond, Petronella G.M. Peer et al. · The Lancet Oncology · 2017 · 157 citations

Medicine, Clinical Trials, Gynecology +10

Influence of body mass index on outcome in advanced colorectal cancer patients receiving chemotherapy with or without targeted therapy

Lieke H. J. Simkens, Miriam Koopman, Linda Mol et al. · European Journal of Cancer · 2011 · 95 citations · Full text

Surgical Oncology, Body Composition, Gastrointestinal Oncology +11